Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02305836Phase 2Unknown
Phase 2, randomised, single-blind trial (2 arms), sponsored by Guang'anmen Hospital. Primary endpoint: Alzheimer's Disease Assessment Scale-Cognitive Subscale at 12 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02305836.